Reaching Herd Immunity During the SARS-CoV-2 Pandemic: What School Nurses Need to Know-Reference-Cited by-同舟云学术

Reaching Herd Immunity During the SARS-CoV-2 Pandemic: What School Nurses Need to Know

Published:2021-11-26 Issue:1 Volume:37 Page:13-18
ISSN:1942-602X
Container-title:NASN School Nurse
language:en
Short-container-title:NASN School Nurse

Author:

Barnby Elizabeth¹^ORCID,Reynolds Mark²^ORCID,Gordon Jenny³

Affiliation:

1. Clinical Associate Professor, University of Alabama in Huntsville, College of Nursing, Huntsville, AL

2. Assistant Professor of Nursing Athens State University, College of Arts and Sciences, Athens, Alabama

3. Registered Nurse, University of Alabama in Huntsville, College of Nursing, Huntsville, AL

Abstract

The National Association of School Nurses supports pandemic control efforts. School nurses are advocates for their students, caregivers, school staff, teachers, and school administrators. With a clear understanding of how the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) virus evolves over time and changes transmissibility through mutations, school nurses gain understanding in epidemiologic calculation of herd immunity. To understand why the estimates of herd immunity fluctuate, as often reported in the news, school nurses need to understand how epidemiologist calculate this number. Obtaining herd immunity will protect the most vulnerable in the population. If all countries have access to vaccines and populations choose to receive vaccinations, herd immunity is more likely to be obtained. Equipped with knowledge of how herd immunity is calculated, school nurses are in a position to educate and advocate for the use of vaccines.

Publisher

SAGE Publications

Subject

General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/1942602X211044996

Reference29 articles.

1. Afifi T. O., Salmon S., Taillieu T., Stewart-Tufescu A., Fortier J., Driedger S. M. (2021). Older adolescents and young adults willingness to receive the COVID-19 vaccine: Implications for informing public health strategies. Vaccine, 39(26), 3473-3479. https://doi.org/10.1016/j.vaccine.2021.05.026

2. Burgos R. M., Badowski M. E., Drwiega E., Ghassemi S., Griffith N., Herald F., Johnson M., Smith R. O., Michienzi S. M. (2021). The race to a COVID-19 vaccine: Opportunities and challenges in development and distribution. Drugs Context, 10. https://doi.org/10.7573/dic.2020-12-2

3. Carvalho T., Krammer F., Iwasaki A. (2021). The first 12 months of COVID-19: A timeline of immunological insights. Nature Reviews Immunology, 21(4), 245-256. https://doi.org/10.1038/s41577-021-00522-1

4. Christie A., Brooks J. T., Hicks L. A., Sauber-Schatz E. K., Yoder J. S., Honein M. A. & CDC COVID-19 Response Team (2021). Guidance for Implementing COVID-19 prevention strategies in the context of varying community transmission levels and vaccination coverage. MMWR Morbidity and Mortality Weekly Report, 70(30), 1044-1047. https://doi.org/10.15585/mmwr.mm7030e2

5. Gettings J., Czarnik M., Morris E., Haller E., Thompson-Paul A., Rasberry C., Lanzieri T., Smith-Grant J., Aholou T., Thomas E., Drenzek C., MacKellar D. (2021). Mask use and ventilation improvements to reduce COVID-19 incidence in elementary schools. MMWR Morbidity and Mortality Weekly Report, 70(21), 779-784. https://doi.org/10.15585/mmwr.mm7021e1